Is Smoking Weed as Bad as Smoking Cigarettes?

Smoking weed and smoking cigarettes both deliver combustion byproducts into your lungs, and many of those byproducts overlap. But the two habits differ enough in their chemistry, typical frequency, and health consequences that calling them equally bad oversimplifies the picture. Cigarettes reliably cause progressive lung disease and lung cancer over time; cannabis smoke causes real airway inflammation and carries its own cardiovascular and mental-health risks, yet has not been linked to the same degree of long-term lung damage. The honest comparison is less “which is worse” and more “worse in which way.”

What Is Actually in the Smoke

Both cannabis and tobacco smoke are complex mixtures of thousands of chemicals. One comprehensive analysis using advanced gas chromatography detected roughly 4,350 compounds in tobacco smoke versus about 2,575 in marijuana smoke. Among those identified, the standout difference was that tobacco smoke contained more aromatic and polycyclic aromatic hydrocarbons (PAHs), a class strongly linked to cancer, while marijuana smoke was richer in terpenes and sesquiterpenes, the compounds that give cannabis its distinctive smell.¹

That does not mean cannabis smoke is clean. A direct comparison of mainstream smoke from joints and cigarettes prepared identically found ammonia levels in marijuana smoke up to 20 times higher than in tobacco smoke. Hydrogen cyanide, nitrogen oxides, and certain aromatic amines showed up at three to five times the concentrations found in tobacco. At the same time, PAH levels were lower in mainstream marijuana smoke than in tobacco, though the reverse was true for the sidestream smoke that drifts into a room.² So the chemical story is not one-sided: each smoke has categories of toxicants where it comes out worse.

People who use both substances together face an additional burden. Biomarker studies show that co-users carry higher blood and urine levels of several toxicant metabolites compared to cigarette-only smokers, including markers tied to known carcinogens.³

How People Smoke Matters

A factor that often gets ignored in these comparisons is the way each substance is smoked. Typical cannabis smoking involves larger puff volumes and much longer breath-hold times than cigarette smoking. Studies measuring these behaviors found that cannabis users tend to hold inhaled smoke for roughly 14 to 16 seconds, compared with about 4 to 5 seconds for a tobacco puff, and take puff volumes around 70 mL versus approximately 45 mL.⁴ Holding hot, particle-laden smoke deep in your lungs for three to four times longer per puff means more tar deposition and more carbon monoxide absorbed per inhalation, even if you smoke fewer total joints in a day than a cigarette smoker lights up.

This difference in technique is one reason researchers have struggled with simple per-cigarette comparisons. A single joint may deposit more tar per session than a single cigarette, but most cannabis users do not smoke 20 joints a day in the way that a pack-a-day cigarette habit works. Frequency and cumulative exposure end up being crucial variables.

Respiratory Symptoms and Airway Damage

If you smoke cannabis regularly, you will probably develop a chronic cough, increased phlegm, and episodes of wheezing. These symptoms overlap heavily with those of cigarette smokers, and most research confirms that the association holds even after adjusting for tobacco use.⁵ Bronchoscopy studies of young, otherwise healthy habitual cannabis smokers have found significant airway inflammation, including increased blood vessel growth in the bronchial lining, tissue swelling, and elevated neutrophil counts. These changes were comparable in frequency and severity to those seen in tobacco smokers of a similar age.⁶

Where the two substances diverge is in what happens to lung function over years of use. Tobacco smoking reliably causes a progressive decline in the volume of air you can forcibly exhale in one second, a hallmark of diseases like emphysema and chronic obstructive pulmonary disease. Cannabis use has not been linked to that same steady decline. A large study tracking adults into midlife found that cannabis was associated with higher overall lung volumes but not with the drop in forced expiratory capacity that tobacco causes.⁷ Cannabis users did show reduced airflow through smaller airways and lower gas transfer efficiency, meaning the lungs were less effective at moving oxygen into the blood. But the pattern looked different from the classic tobacco-related obstruction.

Reviewing the broader evidence, researchers have concluded that habitual marijuana use alone does not appear to cause the kind of significant lung-function abnormalities that lead to a diagnosis of chronic obstructive pulmonary disease.⁸ That is a meaningful distinction. Cigarette smoking is the single biggest cause of that disease worldwide; cannabis has not earned the same accusation despite decades of study.

Cancer Risk

This is the area where many people expect the two to converge, and where the evidence is most surprising. Cannabis smoke contains carcinogens. It causes cellular changes that look precancerous. And yet pooled analyses have repeatedly failed to find a clear, consistent increase in lung cancer risk among habitual cannabis smokers. A large pooled analysis across multiple study sites found that habitual cannabis users had no statistically meaningful increase in lung cancer risk compared to people who never or rarely used cannabis.⁹

Not every study agrees. One case-control study from New Zealand found that the risk of lung cancer rose by about 8% for each joint-year of cannabis use, and the heaviest users had a substantially elevated risk even after accounting for cigarette smoking.¹⁰ The discrepancy between that finding and the null results from pooled analyses has not been fully resolved. Part of the difficulty is that very heavy, long-term cannabis-only smokers who have never touched tobacco are rare in study populations, making it hard to isolate cannabis’s independent contribution.

For head and neck cancers, the picture is similarly muddled. A pooled analysis in the INHANCE Consortium found no association between ever having smoked cannabis and head and neck cancer risk.¹¹ A more recent study focusing on heavy cannabis users estimated that the cancer risk associated with heavy use was slightly less than the two-to-tenfold risk range typically seen with alcohol and tobacco combined.¹² The bottom line on cancer: tobacco’s link is overwhelming and well-established; cannabis’s link is uncertain and, if it exists, appears considerably smaller.

Cardiovascular Effects

Cigarettes are a well-known driver of heart disease, and that risk accumulates steadily with years of use. Cannabis has its own cardiovascular concerns, but they look different. Acute cannabis use can spike blood pressure, trigger rapid heart rate, and has been linked to arrhythmias and even rare cases of heart attack, especially during or shortly after use.¹³

The question of whether long-term cannabis use causes lasting cardiovascular harm is contested. A large cross-sectional analysis of U.S. adults found that daily cannabis users had about a 25% higher odds of heart attack and roughly 42% higher odds of stroke, even after adjusting for other risk factors. Among people who had never smoked tobacco, the associations were even stronger: daily cannabis use was linked to about double the odds of stroke compared to non-users.¹⁴ That finding was concerning, but it came from a survey-based design that can show associations, not causation.

On the other hand, the CARDIA study, which prospectively followed young adults into middle age, found no association between cumulative lifetime marijuana use and incident cardiovascular disease, stroke, coronary heart disease, or cardiovascular death, even when stratified by age, sex, or race.¹⁵ The conflicting results likely reflect differences in study design, population, and how cannabis use was measured. The honest read is that cannabis probably carries some cardiovascular risk, particularly around the time of use, but whether it causes the kind of progressive artery disease that cigarettes cause over decades remains genuinely unclear.

Mental Health and Psychosis

This is a category where cannabis poses a risk that cigarettes do not. Cannabis use, especially starting in adolescence, has been linked to psychotic experiences. A study tracking adolescents found that early-onset cannabis use was associated with roughly 3.7 times the odds of reporting psychotic experiences, and late-onset cannabis use about 3 times the odds, after adjusting for confounders. Early-onset cigarette-only use showed a weaker link that largely disappeared when confounders were controlled for.¹⁶

Using both substances together appears to be the worst combination for psychosis risk. In clinical populations already at high risk for psychosis, co-use of cannabis and tobacco was associated with about 2.5 times the risk of converting to a psychotic disorder compared to using neither, while cannabis alone or tobacco alone did not reach statistical significance on their own.¹⁷ These are correlational findings and do not prove cannabis directly causes psychosis, but the association is strong enough that most psychiatrists consider heavy cannabis use a genuine risk factor for vulnerable individuals.

How Addictive Is Each

Nicotine is substantially more addictive than THC. Population-level data on last-year users have consistently shown nicotine to be the most addictive of the major recreational drugs, including alcohol, marijuana, and cocaine.¹⁸ Roughly 9 to 10% of people who try cannabis develop a dependence on it at some point, compared to about 32% for nicotine. The withdrawal from quitting cannabis is real but milder than nicotine withdrawal, which is notorious for irritability, intense cravings, and difficulty concentrating.

That said, tobacco smoking appears to make cannabis dependence worse. Among young cannabis users in the United Kingdom, cigarette smoking frequency and duration accounted for a significant portion of the variance in cannabis dependence scores, and cigarette use statistically mediated the relationship between how often someone smoked cannabis and how dependent they became.¹⁹ People who mix tobacco into joints, as is common in the UK and Europe, may find it harder to quit cannabis partly because nicotine has hijacked their reward system alongside THC.

Secondhand Smoke

Many people assume cannabis secondhand smoke is less harmful than tobacco, but the available evidence challenges that assumption. In controlled experiments measuring fine particulate matter (PM2.5) across a two-story house, smoking a single marijuana joint produced average particle concentrations about 4.4 times as high as smoking a single tobacco cigarette. Even opening three windows reduced marijuana-smoke particles by only about two-thirds, and levels still exceeded those produced by a closed-window tobacco cigarette.²⁰

The biological effects are concerning, too. In rat studies, just one minute of exposure to marijuana secondhand smoke impaired blood vessel function to a comparable degree as equal concentrations of tobacco secondhand smoke. Recovery took longer after marijuana smoke exposure, suggesting the vascular insult may linger.²¹ This is relevant for anyone living with a cannabis smoker or spending time in enclosed spaces where people smoke.

Memory and the Brain

Cigarettes and cannabis affect cognition differently. Nicotine can temporarily sharpen attention and working memory, though long-term smoking accelerates cognitive decline via vascular damage. Cannabis, by contrast, has a more direct structural effect on the brain. Users of marijuana, whether or not they also smoked tobacco, had smaller hippocampal volumes compared to non-users and tobacco-only smokers, with no significant difference in overall brain volume. Among people who used both substances, a troubling pattern emerged: larger hippocampal size was associated with worse memory performance, the opposite of the normal relationship seen in non-users.²² The implication is that combining the two may disrupt normal brain-behavior relationships in ways that neither substance does alone.

Contaminants You Did Not Sign Up For

Cigarettes are manufactured under regulatory oversight that at least standardizes the product (however toxic it remains). Cannabis, depending on where you live, may have no such quality control. Common contaminants in cannabis include microbes, heavy metals, and pesticides, with potential effects ranging from infection to carcinogenicity and reproductive harm.²³ Testing of light cannabis samples grown in Italy found that 87% contained fungicides or insecticides, and multiple heavy metals exceeded U.S. regulatory limits for inhaled products.²⁴ Even in regulated markets, testing standards vary. In unregulated markets, you have no idea what else you are inhaling.

Pregnancy

Neither substance is safe during pregnancy, but co-use appears to be worse than either alone. Compared with non-using pregnant women, those who used both cannabis and tobacco had about 5.7 times the odds of their baby having a small head circumference and about 3 times the odds of birth defects. Cannabis use alone was associated with dramatically higher odds of stillbirth or miscarriage.²⁵ These findings come from observational data and other factors could play a role, but the effect sizes are large enough that prenatal use of either substance is strongly discouraged by every major medical organization.

Rising Potency, Shifting Perceptions

One complication in comparing today’s cannabis to older studies is that the drug itself has changed. The average THC content of confiscated cannabis in the United States rose from about 4% in 1995 to about 12% in 2014, while cannabidiol content dropped, shifting the THC-to-CBD ratio from about 14:1 to roughly 80:1.²⁶ Concentrates and modern strains can push well above those figures. This means that much of the epidemiological research on cannabis and lung health was conducted on product substantially weaker than what is currently sold, and findings from those studies may underestimate the risks of current use.

Meanwhile, public perception is moving in the opposite direction. Survey data show that the share of U.S. adults who consider daily cannabis smoking safer than daily tobacco smoking rose from about 37% in 2017 to about 44% in 2021. A similar trend applied to secondhand smoke perceptions.²⁷ Young adults rated the perceived harm of cannabis significantly lower than that of tobacco products.²⁸ That gap between increasing potency and decreasing perceived harm is worth paying attention to.

Alternatives to Smoking

One of the simplest ways to reduce harm from cannabis is to stop combusting it. As of 2017, smoking remained the most common way Americans consumed marijuana, used by about 55% of users. But edibles (about 6% of respondents), vaporizers (about 5%), and concentrates and topicals accounted for a growing share.²⁹ Edibles eliminate the respiratory toxicant question entirely, though they carry their own risks around delayed onset and accidental overconsumption. Dry-herb vaporizers heat cannabis below combustion temperature and have been shown to produce fewer toxic byproducts than smoking, though long-term data on vaporizer safety remain thin. The key insight is that most of the respiratory harm from cannabis comes from the act of burning plant material and inhaling the smoke, not from THC or CBD themselves. Tobacco offers no equivalent workaround: nicotine replacement products exist, but they are cessation tools rather than alternative recreational delivery methods.

For people who use cannabis and are concerned about their lungs, switching away from combustion is the single most impactful change available. That is a practical option that cigarette smokers simply do not have if they want to keep using nicotine in a comparable way. Co-use of cannabis and tobacco, whether in blunts, spliffs, or side-by-side habits, appears to add up to more toxicant exposure than either alone and is the pattern most consistently associated with worse outcomes across respiratory, cardiovascular, and mental-health research.³⁰